【プライマリ・ケアでの卵巣癌の発見】プライマリ・ケアではCA125を測定しながらアプローチをhttps://t.co/8lMKdkPLdX https://t.co/9j0Xtyvm2v
@JoelNaftalin @DrSdeG Ovarian cancer risk varies massively based on age and CA125 level (young women + slightly high CA125= low risk). Women could be triaged based on risk e.g. higher risk=urgent investigation, low risk (the vast majority)=reassured. Our t
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @BJGPjournal: Detecting #OvarianCancer in primary care: can we do better? @FunstonGarth ☞ https://t.co/AmUUh2S701 https://t.co/xGOknhD8…
RT @BJGPjournal: Detecting #OvarianCancer in primary care: can we do better? @FunstonGarth ☞ https://t.co/AmUUh2S701 https://t.co/xGOknhD8…
RT @BJGPjournal: Detecting #OvarianCancer in primary care: can we do better? @FunstonGarth ☞ https://t.co/AmUUh2S701 https://t.co/xGOknhD8…
RT @BJGPjournal: Detecting #OvarianCancer in primary care: can we do better? @FunstonGarth ☞ https://t.co/AmUUh2S701 https://t.co/xGOknhD8…
Detecting #OvarianCancer in primary care: can we do better? @FunstonGarth ☞ https://t.co/AmUUh2S701 https://t.co/xGOknhD873
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
“It has been estimated that a 3-month delay in ovarian cancer diagnosis would reduce 10-year net survival by 7-18% for women with the disease, depending on age…” @PCUCancerGrp
RT @PCUCancerGrp: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @PCUCancerGrp: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @PCUCancerGrp: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a lot since then. Can we do better? Here's a new take from @FunstonGarth, @fmw22, @ProfEmmaCrosbie, @BoomboomchiefsT, @CanTest_PC: https:
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
RT @FunstonGarth: The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a…
The current testing pathway for ovarian cancer in primary care was recommended by NICE over a decade ago. We've learnt a lot since then. Can we do better? Here is our take @fmw22 @ProfEmmaCrosbie @BoomboomchiefsT @CanTest_PC @PCU_Cambridge https://t.co